Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2004 / Cilt: 30 - Sayı: 2

Postoperative free and total PSA levels in patients who underwent open prostatectomy for BPH

BPH ön tanısıyla açık prostatektomi uygulanan hastalarda ameliyat sonrası serbest ve total PSA seviyeleri

Pages
235–238
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This PSA level might be taken as a reference range for patients who underwent open prostatectomy if they are suspected to have prostate cancer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The cut-off value of PSA level for screening after radical prostatectomy is 0.2 ng/ml after radical prostatectomy.
📊
Key Findings & Data:But there isn’t any data about the screening value of PSA after surgery for benign disease.
💡
Conclusion & Impact:This PSA level might be taken as a reference range for patients who underwent open prostatectomy if they are suspected to have prostate cancer.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Prostatektomi · Prostat hiperplazisi · Prostata özgü antijen

Abstract

Introduction: The cut-off value of PSA level for screening after radical prostatectomy is 0.2 ng/ml after radical prostatectomy. But there isn&#8217;t any data about the screening value of PSA after surgery for benign disease. The aim of this study is to evaluate the changes of free and total PSA level after open prostatectomy and to determine a baseline PSA level for prostate cancer screening whom underwent open prostatectomy for benign disease. Materials and Methods: During last 3 years, 30 patients who were treated with transvesical prostatectomy for BPH were included in this study prospectively. PSA levels have been measured with monoclonal Tandem R method within 3 months or more after open prostatectomy in all cases. Total and free PSA levels of patients with acute urinary retention are measured 3 weeks after the sistostomy procedure. Patients who were taking finasteride, who were treated for acute bacterial prostatitis and who underwent a transrectal ultrasound (TRUS) guided biopsy were excluded. Prostatectomy was performed transvesically. All total and free PSA levels were measured 3 months after prostatectomy. &#967;2-test was used for statistical analyses. Results: The median age of patients operated was 67 (49- 88) years and the average weight of prostatic tissue removed during operations was 81.5 g. While the average preoperative total PSA level was 11.8 (0.47-54.5) ng/ml, the average preoperative free PSA level was 1.4 (9.5-0.33) ng/ml, the average preoperative free/total PSA level was 0.20; the average postoperative total PSA level is 1.3 (0.11-3.36) ng/ml, the average postoperative free PSA level is 0.18 (0.05-0.92) ng/ml, the average postoperative free/total PSA level is 0.14 ng/ml. The average total PSA level was decreased 10.5 ng/ml (89%); the average postoperative free PSA level decreased 2.28 ng/ml (87%). There was a statistically significant difference between preoperative and postoperative total PSA (p<0.05) and between the removed adenoma tissue and the difference in PSA level (p<0.05). There wasn&#8217;t any association between age related PSA levels and postoperative PSA levels (p>0.05). The decrease of total PSA level per 1 gram of adenoma is 0.128 ng/ml and the decrease of free PSA level per 1 gram of adenoma is 0.027 ng/ml. Conclusion: There is a decrease of baseline average total PSA levels to 1.3±0.99 ng/ml and baseline average free PSA levels to 0.18±0.16 ng/ml after open prostatectomy. Open prostatectomy is performed widely as much as transurethral resection of prostate in Turkey. Because the PSA levels depend heavily on the transitional zone of the prostate, total and free PSA levels decrease after prostatectomy. Data about the PSA levels after transurethral resection of prostate can be found in the literature but there isn&#8217;t any reference PSA value for patients who underwent open prostatectomy and suspected to have a prostate cancer. This PSA level might be taken as a reference range for patients who underwent open prostatectomy if they are suspected to have prostate cancer.

Özet

Bu çalışmamızda, açık prostatektomi sonrası serbest ve total PSA değişikliklerinin belirlenmesi ve daha sonraki prostat kanser taramaları için bazal bir PSA değerinin saptanmasını amaçladık. Son 3 yıl içinde transvesikal prostatektomi yapılan, patoloji sonucu BPH gelen ve aşağıdaki kriterlere uyan 30 hasta prospektif olarak çalışmaya dahil edildi. PSA tüm olgularda monoklonal Tandem R yöntemi ile bakıldı. Açık prostatektomi sonrası PSA ölçümü 3’üncü ay yada daha sonra yapıldı. İstatistiksel analizde χ2 -test kullanıldı. Opere edilen hastaların yaş ortalaması 67, operasyonda çıkarılan ortalama adenom prostat ağırlığı 81.5 gr., ameliyat öncesi total PSA ortalaması 11.8 (0.47-54.5) ng/ml, serbest PSA ortalaması 1.4 (9.5-0.33) ng/ml ve ortalama serbest/total PSA 0.20 olarak bulunurken, ameliyat sonrası total PSA ortalaması 1.3 (0.11-3.36) ng/ml, serbest PSA ortalaması 0.18 (0.05-0.92) ng/ml, ortalama serbest/total PSA 0.14 olarak bulundu. Ameliyat sonrası total PSA’da ortalama %89 azalma ve ortalama serbest PSA’da %87 azalma tespit edildi (p<0.05). Açık prostatektomi sonrası olgularda bazal ortalama PSA seviyesi 1,3±0,99 ng/ml seviyesine inmektedir. Bu değer hastaların prostat kanser takibinde referans oran olarak alınabilir.

🔖

Cite This Article

GÜMÜŞ, E., HORASANLI, K., TANRIVERDİ, O., SOFUOĞLU, S., BOYLU, U., MİROĞLU, C. (2004). Postoperative free and total PSA levels in patients who underwent open prostatectomy for BPH. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 30 - Sayı: 2, 235–238. https://ajindex.com/articles/328438

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Stamey TA, Kabalin JN, McNeal JE, et al: Prostate specific antigen in the diagnosis and tre-atment of adenocarcinoma of the prostate. ІІ. Ra-dical prostatectomy treated patients. J Urol, 141: 1076-1083, 1989
  2. Carter HB, Partin AW, Oesterling JE, et al: The use of prostate specific antigen in the mana-gement of patients with prostate cancer: The John Hopkins experience. In: WJ Catalona, DS Coffey, JP Karr (eds): Clinical Aspects of Prostate Can-cer. New York, Elsevier Science Publishing Co. Sect. ІІІ, pp. 247-251, 1989
  3. Lange PH, Ercole CJ, Lightner DJ, et al: The value of serum prostate specific antigen determi-nations before and after radical prostatectomy. J Urol, 141: 873-879, 1989
  4. Freedland SJ, Sutter ME, Dorey F, et al: Defi-ning the ideal cutpoint for determining PSA re-currence after radical prostatectomy. Urology, 61; 365-369, 2003
  5. Marks LS, Dorey FJ, Rhodes T, et al: Serum prostate specific antigen levels after transurethral resection of prostate: A longitudinal characteriza-tion in men with benign prostatic hyperplasia. J. Urol, 156: 1035-1038, 1996
  6. Stamey TA, Yang N, Hay AR, et al: Prostate specific antigen as a serum marker for adenocar-cinoma of the prostate. New Engl J Med, 317: 909-916, 1987
  7. Lloyd SN, Collins GN, McKelvie GB, et al: Predicted and actual change in serum PSA follo-wing prostatectomy for BPH. Urology, 43: 472-479, 1994
  8. Freyer PJ: A new method of performing prosta-tectomy. Lancet, 1: 774-775, 1900
  9. Aus G, Bergdahl S, Frosing R, et al: Reference range of prostate specific antigen after transureth-ral resection of the prostate. Urology, 47(4): 529-31, 1996
  10. Haab F, Meulemans A, Boccon-Gibod L, et al: Clearance of serum PSA after open surgery for benign prostatic hypertrophy, radical cystectomy, and radical prostatectomy. Prostate, 26(6): 334-8, 1995
  11. Guess HA, Heyse JF, Gormley GJ, et al: Effect of finasteride on serum PSA concentration in men with benign prostatic hyperplasia: Results from the North American Phase III Clinical Trial. Urol Clin North Am, 20: 627-636, 1993
  12. Oesterling JE, Jacobsen SJ, Chute CG, et al: Serum prostate-specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges. JAMA, 270: 860-864, 1993
  13. Tunç M, Erdemir F, Tefekli A: Radikal prosta-tektomi sonrası yükselen PSA’nın değerlendiril-mesi. Türk Üroloji Dergisi, 28(1): 42-7, 2002.